Mirati Therapeutics (MRTX) Q3 2023 Earnings

6NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-3.55
-3.2
-2.84
-2.49

Details

Expected EPS
-2.83
Actual EPS
-2.49
Surprise EPS
0.34
Surprise Percent
+12.01%

Description

Mirati Therapeutics (MRTX) has reported earnings of -2.49 per share for Q3 2023.

0 Comments

Share your thoughts